OSTEOARTHRITIS OF KNEE

We are currently looking for subjects (>18 years old) with knee pain caused by osteoarthritis. Qualified individuals can participate in several studies involving investigational pain medications. As with most studies, a placebo is involved.

HEART ATTACK

We are conducting a research study of the investigational use of a medication in its ability to reduce your risk of future heart attacks and other cardiovascular events such as a stroke. You may qualify to participate if you have had at least one heart attack. Participants may continue their current medications throughout the study. All study-related care and study medication will be provided at no cost.

ASTHMA

We are currently looking for subjects (≥12 years old) with asthma for FDA approved medications. This outcome study will evaluate the serious asthma related events from the use of approved drugs. The subjects will participate in the study for a maximum of 29 weeks.

COPD

We are currently looking for subjects (≥40 and ≤80 years of age) with chronic obstructive pulmonary disease (COPD) for FDA approved medications. This outcome study will evaluate the effect of the medication on subjects with moderate COPD and a history of, or at increased risk of cardiovascular disease. The total duration of the subject participation will be approximately between 15 and 44 months.

RHEUMATOID ARTHRITIS

We are currently participating in several clinical trials involving investigational medications (biologics or monoclonal antibodies) for the treatment of rheumatoid arthritis. Qualified subjects will receive all study-related care and study medications at no cost.

LUPUS

Subjects who are diagnosed with lupus can participate in couple of research studies involving investigational medications (biologics or monoclonal antibodies) for the treatment of lupus.

TYPE II DIABETES

We are currently looking for subjects with type II diabetes. Qualified individuals can participate in studies involving anti-diabetes investigational medications (inhaled insulin).

RESTLESS LEG SYNDROME

We are conducting research studies involving FDA-approved medications for the treatment of restless leg syndrome. All study-related care and study medication will be provided at no cost.

EPILEPSY

Subjects with partial-onset seizures can participate in a research study involving investigational medication. Subjects who had primary generalized or unclassified seizures won’t qualify in the study.

ATHLETE’S FOOT

We are currently looking for subjects in a research study involving investigational medication for the treatment of athlete’s foot. All study related procedures will be provided at no cost.

ANKYLOSING SPONDYLITIS

Subjects diagnosed with ankylosing spondylitis can participate in a clinical study involving investigational medication for the treatment of the disease. All study related procedures will be provided at no cost.

FROZEN SHOULDER

We are currently looking for subjects with frozen shoulder (adhesive capsulitis of the shoulder) for a research study involving investigational medication. All study related procedures will be provided at no cost.

IRRITABLE BOWEL SYNDROME

Subjects experiencing irritable bowel syndrome with recurrent diarrhea can participate in a new research study involving investigational medication. All study related procedures will be provided at no cost.